Amid a spate of biopharma CEO pivots, two prominent contract manufacturers from Europe are getting in on the action. Monday, Rentschler revealed its chief executive, Frank Mathias, Ph.D., was stepping ...
Rentschler Biopharma announced this week that it is searching for a new CEO as its current leader Dr. Frank Mathias will return to the company’s supervisory board. Mathias, who has led Rentschler ...
Dr. Frank Mathias joined Rentschler Biopharma SE’s Supervisory Board in 2013 and was appointed Chief Executive Officer and Chairman of the Executive Board in April 2016. LAUPHEIM, Germany, Nov. 21, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results